Singapúr - enska - HSA (Health Sciences Authority)

medtronic international, ltd. - cardiovascular - intended to be used with current medtronic® vdd pacemakers for bipolar sensing in the atrium, and bipolar sensing and pacing in the ventricle.

Singapúr - enska - HSA (Health Sciences Authority)

medtronic international, ltd. - cardiovascular - intended for the downloading and transport of data from implanted medtronic medical devices.

Singapúr - enska - HSA (Health Sciences Authority)

medtronic international, ltd. - cardiovascular - sfa and ppa: the complete se vascular stent system is indicated to improve luminal diameter in symptomatic patients with de novo and/or restenotic lesions or occlusions of the superficial femoral artery (sfa) or proximal popliteal artery (ppa) with reference diameters ranging from 4 mm to 7 mm and lesion lengths up to 140 mm. iliac: the medtronic vascular complete se vascular stent system is indicated for improving luminal diameter in patients with iliac stenosis in previously unstented lesions with vessel reference diameters between 4.5 mm and 9.5 mm and lesion lengths up to 110 mm. the stent is intended as a permanent implant.

Singapúr - enska - HSA (Health Sciences Authority)

medtronic international, ltd. - cardiovascular - the medtronic corevalve™ system is indicated for use in patients with symptomatic heart disease due to either severe native calcific aortic stenosis or failure (stenosed, insufficient, or combined) of a surgical bioprosthetic aortic valve who are judged by a heart team, including a cardiac surgeon, to be at high or greater risk for open surgical therapy (i.e., society of thoracic surgeons operative risk score ≥8% or at a ≥15% risk of mortality at 30 days).

Singapúr - enska - HSA (Health Sciences Authority)

medtronic international, ltd. - cardiovascular - the medtronic corevalve™ system is indicated for use in patients with symptomatic heart disease due to either severe native calcific aortic stenosis or failure (stenosed, insufficient, or combined) of a surgical bioprosthetic aortic valve who are judged by a heart team, including a cardiac surgeon, to be at high or greater risk for open surgical therapy (i.e., society of thoracic surgeons operative risk score ≥8% or at a ≥15% risk of mortality at 30 days).

Singapúr - enska - HSA (Health Sciences Authority)

medtronic international, ltd. - general hospital - intended for use with medtronic diabetes (medtronic) glucose sensing systems to continuously monitor glucose levels in persons with diabetes. enlite sensor values are not intended to be used directly for therapy decisions. the enlite™ insertion device (serter) is indicated for use as an aid for inserting the enlite™ glucose sensor (sensor).

Singapúr - enska - HSA (Health Sciences Authority)

medtronic international, ltd. - general hospital - the medtronic minimed 640g system is indicated for the continuous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in persons requiring insulin. in addition, the system is indicated for continuous or periodic monitoring of glucose levels in the fluid under the skin, and possible low and high blood glucose episodes.

Singapúr - enska - HSA (Health Sciences Authority)

medtronic international, ltd. - cardiovascular - the medtronic open pivot heart valve is intended for use as a replacement valve in patients with diseased, damaged, or malfunctioning heart valves. this device may also be used to replace a previously implanted prosthetic heart valve.

Singapúr - enska - HSA (Health Sciences Authority)

medtronic international, ltd. - cardiovascular - the medtronic open pivot heart valve is intended for use as a replacement valve in patients with diseased, damaged, or malfunctioning heart valves. this device may also be used to replace a previously implanted prosthetic heart valve.

Singapúr - enska - HSA (Health Sciences Authority)

medtronic international, ltd. - cardiovascular - the medtronic open pivot heart valve is intended for use as a replacement valve in patients with diseased, damaged, or malfunctioning heart valves. this device may also be used to replace a previously implanted prosthetic heart valve.